537 related articles for article (PubMed ID: 21193545)
1. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
Kandaraki E; Chatzigeorgiou A; Livadas S; Palioura E; Economou F; Koutsilieris M; Palimeri S; Panidis D; Diamanti-Kandarakis E
J Clin Endocrinol Metab; 2011 Mar; 96(3):E480-4. PubMed ID: 21193545
[TBL] [Abstract][Full Text] [Related]
2. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome.
Konieczna A; Rachoń D; Owczarek K; Kubica P; Kowalewska A; Kudłak B; Wasik A; Namieśnik J
Reprod Toxicol; 2018 Dec; 82():32-37. PubMed ID: 30266220
[TBL] [Abstract][Full Text] [Related]
3. [Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation].
Li TT; Xu LZ; Chen YH; Deng HM; Liang CY; Liu Y; Liu XF; Zhang J; Kang DY; Qiu DS; Han DW; Hu R
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1753-6. PubMed ID: 22027783
[TBL] [Abstract][Full Text] [Related]
4. The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls.
Akın L; Kendirci M; Narin F; Kurtoglu S; Saraymen R; Kondolot M; Koçak S; Elmali F
Acta Paediatr; 2015 Apr; 104(4):e171-7. PubMed ID: 25469562
[TBL] [Abstract][Full Text] [Related]
5. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis.
Hu Y; Wen S; Yuan D; Peng L; Zeng R; Yang Z; Liu Q; Xu L; Kang D
Gynecol Endocrinol; 2018 May; 34(5):370-377. PubMed ID: 29191127
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
Palioura E; Diamanti-Kandarakis E
Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.
Tarantino G; Valentino R; Di Somma C; D'Esposito V; Passaretti F; Pizza G; Brancato V; Orio F; Formisano P; Colao A; Savastano S
Clin Endocrinol (Oxf); 2013 Mar; 78(3):447-53. PubMed ID: 22805002
[TBL] [Abstract][Full Text] [Related]
8. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.
O'Connor A; Phelan N; Tun TK; Boran G; Gibney J; Roche HM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1378-85. PubMed ID: 20080859
[TBL] [Abstract][Full Text] [Related]
9. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.
Vahedi M; Saeedi A; Poorbaghi SL; Sepehrimanesh M; Fattahi M
Environ Sci Pollut Res Int; 2016 Dec; 23(23):23546-23550. PubMed ID: 27614642
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
Rutkowska A; Rachoń D
Gynecol Endocrinol; 2014 Apr; 30(4):260-5. PubMed ID: 24397396
[TBL] [Abstract][Full Text] [Related]
12. Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels.
Takeuchi T; Tsutsumi O
Biochem Biophys Res Commun; 2002 Feb; 291(1):76-8. PubMed ID: 11829464
[TBL] [Abstract][Full Text] [Related]
13. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
14. Bisphenol A and polycystic ovary syndrome in human: A systematic review.
Urbanetz LAML; Soares-Junior JM; Dos Santos Simões R; Maciel GAR; Baracat MCP; Baracat EC
Int J Gynaecol Obstet; 2024 Jul; 166(1):190-203. PubMed ID: 38197560
[TBL] [Abstract][Full Text] [Related]
15. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
17. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.
Papalou O; Livadas S; Karachalios A; Tolia N; Kokkoris P; Tripolitakis K; Diamanti-Kandarakis E
Hormones (Athens); 2015; 14(1):91-100. PubMed ID: 25553762
[TBL] [Abstract][Full Text] [Related]
18. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
19. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
20. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]